Kaneku H - Search Results

1

Donor-specific HLA antibody response in clonal deletion.

Kaneku H, Idica A, Everly MJ, Terasaki PI, Feroz A, Vanikar AV, Shankar V, Trivedi VB, Modi PR, Khemchandani SI, Dave SD, Trivedi HL. Kaneku H, et al. Clin Transpl. 2008:189-98. Clin Transpl. 2008. PMID: 19708456

2

Elimination of post-transplant donor-specific HLA antibodies with bortezomib.

Idica A, Kaneku H, Everly MJ, Trivedi HL, Feroz A, Vanikar AV, Shankar V, Trivedi VB, Modi PR, Khemchandani SI, Dave SD, Terasaki PI. Idica A, et al. Among authors: kaneku h. Clin Transpl. 2008:229-39. Clin Transpl. 2008. PMID: 19708459

3

Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients.

Trivedi HL, Kaneku H, Terasaki PI, Feroz A, Vanikar AV, Trivedi VB, Khemchandani SI, Dave SD, Modi PR, Jahr F, Idica A, Everly MJ. Trivedi HL, et al. Among authors: kaneku h. Clin Transpl. 2009:265-80. Clin Transpl. 2009. PMID: 20524291

4

Impact of the presence and duration of donor-specific antibodies on renal function.

Hoshino J, Everly MJ, Kaneku H, Ubara Y, Takaichi K, Terasaki PI. Hoshino J, et al. Among authors: kaneku h. Transplant Proc. 2014 Jan-Feb;46(1):75-80. doi: 10.1016/j.transproceed.2013.09.032. Transplant Proc. 2014. PMID: 24507029

5

A "new" road to tolerance: clonal deletion and drugs added when needed (DAWN).

Terasaki PI, Everly ML, Kaneku H, Hoshino J, Vanikar AV, Patel HV, Shah PR, Trivedi HL. Terasaki PI, et al. Among authors: kaneku h. Clin Transpl. 2010:253-60. Clin Transpl. 2010. PMID: 21698835

6

Using donor-specific antibodies to monitor the need for immunosuppression.

Hoshino J, Kaneku H, Everly MJ, Greenland S, Terasaki PI. Hoshino J, et al. Among authors: kaneku h. Transplantation. 2012 Jun 15;93(11):1173-8. doi: 10.1097/TP.0b013e31824f3d7c. Transplantation. 2012. PMID: 22592887 Clinical Trial.

7

Removal of physiologic corticosteroid doses results in HLA antibody appearance and allograft dysfunction in patients transplanted under a clonal deletion protocol.

Everly MJ, Jahr F, Kaneku H, Trivedi HL, Terasaki PI. Everly MJ, et al. Among authors: kaneku h. Clin Transpl. 2009:281-93. Clin Transpl. 2009. PMID: 20524292

8

A review of the past 25 years of "Clinical Transplants".

Kaneku H, Terasaki PI. Kaneku H, et al. Clin Transpl. 2009:1-39. Clin Transpl. 2009. PMID: 20527067 No abstract available.

9

De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Kaneku H, O'Leary JG, Banuelos N, Jennings LW, Susskind BM, Klintmalm GB, Terasaki PI. Kaneku H, et al. Am J Transplant. 2013 Jun;13(6):1541-8. doi: 10.1002/ajt.12212. Am J Transplant. 2013. PMID: 23721554 Free PMC article.

10

Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.

Kaneku H, O'Leary JG, Taniguchi M, Susskind BM, Terasaki PI, Klintmalm GB. Kaneku H, et al. Liver Transpl. 2012 Aug;18(8):984-92. doi: 10.1002/lt.23451. Liver Transpl. 2012. PMID: 22508525 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters